21-Protein blood test aims to spot hidden heart failure in the ER

NCT ID NCT04886128

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study aims to improve how doctors diagnose acute heart failure in the emergency department. Currently, diagnosis can be slow and uncertain because symptoms like shortness of breath are vague. Researchers are testing a blood test that measures 21 different proteins to see if it can more accurately identify heart failure, helping patients get the right treatment sooner. The study involves adults who come to the ER with shortness of breath and are being checked for heart failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
multi-marker blood test (21 proteins)
What this could lead to
If successful, this blood test could help doctors diagnose acute heart failure faster and more accurately in the emergency room, leading to quicker treatment.
What could go wrong
This is a diagnostic study, not a treatment. The test may not prove accurate enough in practice, and it is still being developed and validated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.